Table 1.
Characteristic | pSS (n = 24) | Non-pSS sicca (n = 16) | Controls (n = 25) |
---|---|---|---|
Age (years) | 49.0 ± 15.8 | 52.8 ± 15.4 | 59.0 ± 12.0 |
Female:male | 21:3 | 13:3 | 12:13 |
Ethnicity | 24 Caucasian | 16 Caucasian | 25 Caucasian |
Unstimulated whole saliva (ml/minute) | 0.10 ± 0.14 | 0.12 ± 0.18 | NA |
Stimulated whole saliva (ml/minute) | 0.31 ± 0.35 | 0.33 ± 0.40 | NA |
Schirmer's test (mm) | 9.2 ± 7.6 | 14.8 ± 11.7 | NA |
Focal score | 3.5 ± 1.2 | 0.5 ± 1.0 | 0 |
Sjögren's syndrome - A (positive:negative) | 23:1 | 2:14 | 0:25 |
Sjögren's syndrome - B (positive:negative) | 19:5 | 0:16 | 0:25 |
Data presented as the mean ± standard deviation. All primary Sjögren's syndrome (pSS) and non-pSS sicca patients were subjected to a complete American-European Consensus Group diagnostic work-up. NA, not assessed (in controls being head and neck cancer patients without parotid involvement, no functional tests were performed as all these patients were already scheduled for a neck dissection and functional tests were considered too much of a burden to the patients at that time).